Source 1primary paper2023Clinical and Translational Medicine
Toolkit/nanobody-mediated proteolysis-targeting chimeras
nanobody-mediated proteolysis-targeting chimeras
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Nanobody-mediated proteolysis-targeting chimeras are a degradation-based engineering method used in an optogenetically coordinated platform to regulate the intracellular factor Survivin in cancer cells. In the cited study context, they are combined with split-Cas9-based targeted gene editing for multi-level control of cancer cell fate.
Usefulness & Problems
Why this is useful
This method is useful as part of a coordinated regulatory strategy that offers controllability and targeting for controlling the fate of cancer cells through multi-level regulation of key intracellular factors. The cited application specifically uses nanobody-mediated proteolysis-targeting chimeras to regulate Survivin under optogenetic coordination.
Source:
the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
Problem solved
The method addresses the problem of controlling cancer cell fate through targeted regulation of an intracellular factor, specifically Survivin. The source further places it within a combinable platform for multi-level regulation together with split-Cas9-based targeted gene editing.
Source:
the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete method used to build, optimize, or evolve an engineered system.
Techniques
No technique tags yet.
Target processes
degradationeditingInput: Light
Implementation Constraints
The available evidence indicates use in cancer cells and coordination with split-Cas9-based targeted gene editing under light-controlled regulation of Survivin. No further practical details are provided on construct design, nanobody specificity, delivery method, cofactors, or expression system.
The provided evidence does not specify the molecular architecture, degradation efficiency, temporal response, or validation across cell types or in vivo models. It also does not identify the exact optogenetic module, E3 ligase components, or quantitative performance metrics.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Coordinated regulatory strategies and combinable technology platforms offer advantages in controllability and targeting for controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
Coordinated regulatory strategies and combinable technology platforms offer advantages in controllability and targeting for controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
Coordinated regulatory strategies and combinable technology platforms offer advantages in controllability and targeting for controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
Coordinated regulatory strategies and combinable technology platforms offer advantages in controllability and targeting for controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
Coordinated regulatory strategies and combinable technology platforms offer advantages in controllability and targeting for controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
Coordinated regulatory strategies and combinable technology platforms offer advantages in controllability and targeting for controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
Coordinated regulatory strategies and combinable technology platforms offer advantages in controllability and targeting for controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras are used for optogenetically coordinated regulation of Survivin to control the fate of cancer cells.
Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras are used for optogenetically coordinated regulation of Survivin to control the fate of cancer cells.
Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras are used for optogenetically coordinated regulation of Survivin to control the fate of cancer cells.
Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras are used for optogenetically coordinated regulation of Survivin to control the fate of cancer cells.
Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras are used for optogenetically coordinated regulation of Survivin to control the fate of cancer cells.
Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras are used for optogenetically coordinated regulation of Survivin to control the fate of cancer cells.
Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras are used for optogenetically coordinated regulation of Survivin to control the fate of cancer cells.
Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
Approval Evidence
1 source2 linked approval claimsfirst-pass slug nanobody-mediated-proteolysis-targeting-chimeras
nanobody‐mediated proteolysis‐targeting chimeras
Source:
application scopesupports
Coordinated regulatory strategies and combinable technology platforms offer advantages in controllability and targeting for controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi-level regulation of key intracellular factors.
Source:
target regulationsupports
Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras are used for optogenetically coordinated regulation of Survivin to control the fate of cancer cells.
Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
Source:
Comparisons
Source-backed strengths
The reported strength is its inclusion in a coordinated and combinable technology platform described as advantageous in controllability and targeting. It is specifically applied to optogenetically coordinated regulation of Survivin in cancer cells.
Ranked Citations
- 1.